Amanote Research
Register
Sign In
Cardiac Toxicity of HER-2 Targeted Regimens
doi 10.1016/b978-0-323-58122-6.00010-6
Full Text
Open PDF
Abstract
Available in
full text
Date
January 1, 2019
Authors
Mirela Tuzovic
Megha Agarwal
Nidhi Thareja
Eric H. Yang
Publisher
Elsevier
Related search
Potential of Molecular Targeted Therapy of HER-2 and Cox-2 for Invasive Transitional Cell Carcinoma of the Urinary Bladder
Oncology Reports
Medicine
Cancer Research
Oncology
Sorafenib Combined With HER-2 Targeted Vaccination Can Promote Effective T Cell Immunity in Vivo
International Immunopharmacology
Allergy
Immunology
Pharmacology
Development of Conditioning Regimens Based on HSC-Targeted Antibody ACK2
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Clinical Experience of Dual Targeted Blockade (Pertuzumab + Trastuzumab + Docetaxel) in Neoadjuvant Therapy of Early HER-2-Positive Breast Cancer
Effective Pharmacotherapy
Cardiac Toxicity of High-Dose Chemotherapy
Bone Marrow Transplantation
Transplantation
Hematology
PET Imaging of HER-2-positive Tumours
European Journal of Nuclear Medicine and Molecular Imaging
Medicine
Nuclear Medicine
Radiology
Imaging
Role of Conditioning Regimens in Pediatric Hematopoietic Stem Cell Transplant for Malignant Disorders: Reduced Toxicity Versus Standard Myeloablative Regimens
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics
Circulation Research
Cardiovascular Medicine
Physiology
Cardiology
Impact of Polysomy 17 on HER-2/neu Immunohistochemistry in Breast Carcinomas Without HER-2/neu Gene Amplification
Journal of Molecular Diagnostics
Forensic Medicine
Pathology
Molecular Medicine
